Franz-Josef Van Der Staay

This inventor holds 10 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1998-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franz-Josef Van Der Staay. Retrieved from https://idiyas.com/inventor/franz-josef-van-der-staay-l5ncu01a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10

% Patents Active = 70.0

Average Co-Inventor Count = 10.7

ph-index = 7

Forward Citations = 118(Granted Patents)

Location History:

Lohmar/Wahlscheid, DE (1998 - 2001)
Lohmar-Wahlscheid, DE (2002)
Lohmar, DE (2003 - 2006)

Company Filing History:

10 out of 12,269

Bayer Aktiengesellschaft

patents

Years Active: 1998-2006

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6998402 - Substituted imidazotriazinones (2006-02-14),

2. 6589949 - 3-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseases (2003-07-08),

3. 6573263 - Substituted imidazotriazinones (2003-06-03),

4. 6344471 - 2-aminocarbonyl-5(2H)-isoxazolones as ligands of a DFP-binding site treatment of CNS-diseases (2002-02-05),

5. 6174897 - Bis-(quinolyl)-diamines (2001-01-16),

6. 5874438 - 2,2'-bridged bis-2,4-diaminoquinazolines (1999-02-23),

7. 5866562 - Ring-bridged bis-quinolines (1999-02-02),

8. 5760230 - 4, 4'-bridged bis-2, 4-diaminoquinazolines (1998-06-02),

9. 5756517 - Use of bisquinoline compounds in the treatment of cerebral disorders (1998-05-26),

10. 5739127 - 2,4'-bridged bis-2,4-diaminoquinazolines (1998-04-14),

Title: **Franz-Josef Van Der Staay: Innovator in Medicinal Chemistry**

Introduction

Franz-Josef Van Der Staay, located in Lohmar, Germany, is a prominent inventor known for his substantial contributions to medicinal chemistry. With a remarkable portfolio of 10 patents, his work primarily focuses on compounds that enhance cognitive functions and combat central nervous system diseases.

Latest Patents

Among his latest innovations are the "Substituted imidazotriazinones," which are novel compounds designed to improve perception, concentration, learning capacity, and memory retentiveness. His other significant invention is the "3-oxo-2,1-benzisoxazol-1(3H)-carboxamides" targeting treatments for CNS diseases. This invention includes a range of specialized compounds that have shown potential in addressing cognitive disorders, including Alzheimer's and other forms of dementia.

Career Highlights

Franz-Josef Van Der Staay is affiliated with Bayer Aktiengesellschaft, a leading multinational corporation focusing on life sciences. His innovative approach and dedication to research have led to groundbreaking developments in the pharmaceutical industry.

Collaborations

Throughout his career, Van Der Staay has collaborated with notable professionals in the field, including Joachim Schuhmacher and Bernard Schmidt. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

Franz-Josef Van Der Staay stands out as a visionary inventor whose work continues to influence the medical field. His numerous patents reflect a commitment to advancing science and improving human health through innovation.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]